ask="2.60"
ask_size="600"
average_daily_volume="341268"
bid="2.25"
bid_size="900"
book_value="0.88"
change="+0.30"
change_from_200_day_moving_average="-1.82"
change_from_50_day_moving_average="-0.20"
change_from_52_week_high="-4.58"
change_From_52_week_low="0.57"
change_in_percent="+14.63%"
close="2.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.35"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.11"
ex_dividend_date="N/A"
float_shares="25741000"
high="2.35"
high_52_weeks="6.93"
last_trade_date="1/4/2017"
last_trade_price="2.35"
last_trade_size="5411"
last_trade_time="4:00pm"
low="2.05"
low_52_weeks="1.77"
market_capitalization="71.95M"
moving_average_200_day="4.17"
moving_average_50_day="2.55"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.17"
open="2.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-43.67%"
percent_change_from_50_day_moving_average="-7.88%"
percent_change_from_52_week_high="-66.09%"
percent_change_from_52_week_low="+32.39%"
previous_close="2.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.34"
price_per_sales="160.04"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="5.20"
stock_exchange="NCM"
symbol="TROV"
volume="330592"
weeks_range_52="1.77 - 6.93"
